Data as of November 21, 2026

Bystolic 2.5 mg Tablet

NEBIVOLOL HYDROCHLORIDE

Brand: Bystolic

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$283.45/ fill$6.44 / EA
VA Big4
$203.32/ fill$4.62 / EA
FUL
$8.13/ fill$0.18 / EA
AMP
$4.64/ fill$0.11 / EA
Medicaid FFS
$224.35/ fill
Medicaid MCO
$331.82/ fill

Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/ful:generic-ceiling · cms/sdud

What's in the reimbursement

Ingredient cost (44 units/fill)$283.45
Dispensing fee & other (state-fixed, not margin)-$59.10
Total reimbursed per fill$224.35

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 4 fee-for-service states, 2 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-11-11; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology